Complete title: A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
| Research Study Number | RG1007066 |
| Principal Investigator | Terry Gernsheimer, MD |
| Phase | III |
To establish the efficacy of fostamatinib in placebo crossover subjects with warm antibody autoimmune hemolytic anemia (wAIHA)
To determine the ability to maintain a response in subjects receiving fostamatinib for wAIHA
Other eligibility criteria may apply.
| Research Study Number | RG1007066 |
Keywords: Anemia, Hemolytic, Autoimmune
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
Talk to your health care providers first before making decisions about your health care.
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.